Muscle Tension Dysphonia Treatment Market size is anticipated to reach USD 20 Billion by the end of 2036, growing at a CAGR of 3% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of muscle tension dysphonia treatment was over USD 13 Billion. The market for muscle tension dysphonia is growing as vocal issues become more common. The market for muscular tension dysphonia treatment offers a range of diagnostic procedures, including laryngoscopy and stroboscopy, evaluation of speech-language pathology, and search for further abnormalities that may be related. As per a report in 2019, a third of cases of dysphonia were reported by workers in the service sector. According to estimates, those who work in the service sector have a 2.6-fold increased risk of benign laryngeal development. Voice issues were estimated to affect 46% of vocalists on average. Therefore, these factors are propelling the growth of the muscle tension dysphonia treatment market.
Anxiety and stress may be linked to muscle tension dysphonia. This frequently happens after contracting a cold flu, or other upper respiratory infection. Muscle tension dysphonia is frequently accompanied by a variety of symptoms, such as an uneven voice, difficulty singing, a broken or airy voice, vocal fatigue, a rough and hoarse voice, etc.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~ 3% |
|
Base Year Market Size (2023) |
~ USD 13 Billion |
|
Forecast Year Market Size (2036) |
~ USD 20 Billion |
|
Regional Scope |
|
Age Group (Pediatrics, Adults, Elderly)
The adults segment in the muscle tension dysphonia treatment market is poised to hold the largest share of 46% during the forecast period. The segment's expansion can be linked to the rise in adult cases of muscle tension dysphonia. Numerous causes, including overuse of the voice, stress, and incorrect vocal technique—all of which are more common in adults—can contribute to this illness. Adults may also seek treatment for muscular tension dysphonia to enhance their social or professional communication abilities. According to a report, in 2023 disabilities in communication affect about 10% of people worldwide. The desire for treatment options, such as voice therapy, is driving the expansion of the adult segment as knowledge of the issue rises and more adults realize how muscular tension dysphonia affects their day-to-day lives.
Treatment Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Proton-pump Inhibitors, Analgesics, Antacids, Voice Therapy, Behavioural Counseling)
The voice therapy segment in muscle tension dysphonia treatment market is anticipated to hold a share of 34% during the forecast period. The segment is expanding because it provides a successful and non-invasive method of treating the illness. The main goals of voice therapy are to promote healthy vocal habits, ease muscular tension, and enhance vocal technique. It gives people the skills and methods they need to take back control of their voice and reduce symptoms. Since voice therapy can significantly improve voice quality and lessen vocal strain, it is frequently advised as a first-line treatment for muscular tension dysphonia. The voice treatment services are expected to increase as more people become aware of the advantages of voice therapy and as more medical professionals become specialists in this field. Additionally, the efficacy of voice treatment strategies and approaches has improved due to technological and medical developments. Therefore, altogether these factors contribute to the growth of the voice therapy segment.
Our in-depth analysis of the global muscle tension dysphonia treatment market includes the following segments:
|
Treatment Type |
|
|
Age Group |
|
|
Distribution Channel |
|
North American Market Forecast
The North American muscle tension dysphonia treatment market is expected to hold the largest share of 37% during the forecast period. The condition is growing more widely recognized and understood, which is driving up demand for available treatment alternatives. Many medical specialists who treat muscular tension dysphonia specifically in North America include otolaryngologists and speech-language pathologists. These specialists specialize in voice abnormalities. According to a report in 2021, more than 17,837 speech therapists were working in the US. Women accounted for 91.0% of speech therapists, and men made up 9.0%. Furthermore, improvements in research and development have made it possible to implement more individualized and successful treatment plans. The need for skilled specialists and the increasing focus on vocal health are likely to fuel the growth of the muscle tension dysphonia treatment market in North America.
European Market Statistics
Europe muscle tension dysphonia treatment market is anticipated to grow gradually with a share of 28% during the forecast period. The region's increasing prevalence of chronic conditions like autism, brain tumors, and cerebral palsy is thought to be the reason for the market's rise. Additionally, muscular tension dysphonia has grown more easily diagnosed and treated, making it more accessible to people in Europe thanks to increased scientific and technological breakthroughs. One such development is the use of biofeedback devices, which enable people with muscular tension dysphonia to monitor and modify their vocal behaviors in real-time through visual or audio input. This can help to promote better vocal production and ease excessive strain.
Author Credits: Radhika Gupta, Shivam Bhutani
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?